AlzeCure Pharma has been granted approval by Swedish regulatory authorities to start its third Phase 1 study of ACD856,…
Articles by Margarida Maia, PhD
SciSparc is set to start a Phase 2a study evaluating the safety and efficacy of SCI-110, its investigational cannabinoid-based…
Note: This story was updated July 7, 2021, to reflect that patients with two copies of the APOE4 gene are…
Based on new evidence from an ongoing Phase 2b clinical trial, the U.S. Food and Drug Administration (FDA) has granted…
A first patient has been dosed in APOLLOE4, a Phase 3 trial testing the efficacy and safety of ALZ-801,…
A $10.7-million grant to investigate the genetic underpinnings of Alzheimer’s disease has been awarded to the University of Pittsburgh…